610 related articles for article (PubMed ID: 24472611)
1. Differential relative effect potencies of some dioxin-like compounds in human peripheral blood lymphocytes and murine splenic cells.
van Ede KI; Gaisch KP; van den Berg M; van Duursen MB
Toxicol Lett; 2014 Apr; 226(1):43-52. PubMed ID: 24472611
[TBL] [Abstract][Full Text] [Related]
2. Relative effect potency estimates of dioxin-like activity for dioxins, furans, and dioxin-like PCBs in adults based on cytochrome P450 1A1 and 1B1 gene expression in blood.
Wimmerová S; van den Berg M; Chovancová J; Patayová H; Jusko TA; van Duursen MB; Palkovičová Murínová Ľ; Canton RF; van Ede KI; Trnovec T
Environ Int; 2016 Nov; 96():24-33. PubMed ID: 27588699
[TBL] [Abstract][Full Text] [Related]
3. Comparison of intake and systemic relative effect potencies of dioxin-like compounds in female rats after a single oral dose.
van Ede KI; Andersson PL; Gaisch KP; van den Berg M; van Duursen MB
Arch Toxicol; 2014 Mar; 88(3):637-46. PubMed ID: 24363026
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the CYP1A1 mRNA dose-response in human keratinocytes indicates that relative potencies of dioxins, furans, and PCBs are species and congener specific.
Sutter CH; Bodreddigari S; Sutter TR; Carlson EA; Silkworth JB
Toxicol Sci; 2010 Dec; 118(2):704-15. PubMed ID: 20819910
[TBL] [Abstract][Full Text] [Related]
5. Consensus toxicity factors for polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls combining in silico models and extensive in vitro screening of AhR-mediated effects in human and rodent cells.
Larsson M; van den Berg M; Brenerová P; van Duursen MB; van Ede KI; Lohr C; Luecke-Johansson S; Machala M; Neser S; Pěnčíková K; Poellinger L; Schrenk D; Strapáčová S; Vondráček J; Andersson PL
Chem Res Toxicol; 2015 Apr; 28(4):641-50. PubMed ID: 25654323
[TBL] [Abstract][Full Text] [Related]
6. Comparison of intake and systemic relative effect potencies of dioxin-like compounds in female mice after a single oral dose.
van Ede KI; Andersson PL; Gaisch KP; van den Berg M; van Duursen MB
Environ Health Perspect; 2013 Jul; 121(7):847-53. PubMed ID: 23674508
[TBL] [Abstract][Full Text] [Related]
7. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in silico derived relative effect potencies of ah-receptor-mediated effects by PCDD/Fs and PCBs in rat, mouse, and guinea pig CALUX cell lines.
Ghorbanzadeh M; van Ede KI; Larsson M; van Duursen MB; Poellinger L; Lücke-Johansson S; Machala M; Pěnčíková K; Vondráček J; van den Berg M; Denison MS; Ringsted T; Andersson PL
Chem Res Toxicol; 2014 Jul; 27(7):1120-32. PubMed ID: 24901989
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 1A1 and 1B1 in human blood lymphocytes are not suitable as biomarkers of exposure to dioxin-like compounds: polymorphisms and interindividual variation in expression and inducibility.
van Duursen MB; Sanderson JT; van den Berg M
Toxicol Sci; 2005 May; 85(1):703-12. PubMed ID: 15659568
[TBL] [Abstract][Full Text] [Related]
10. Relative potency based on hepatic enzyme induction predicts immunosuppressive effects of a mixture of PCDDS/PCDFS and PCBS.
Smialowicz RJ; DeVito MJ; Williams WC; Birnbaum LS
Toxicol Appl Pharmacol; 2008 Mar; 227(3):477-84. PubMed ID: 18190939
[TBL] [Abstract][Full Text] [Related]
11. Relative potencies of polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls derived from hepatic porphyrin accumulation in mice.
van Birgelen AP; DeVito MJ; Akins JM; Ross DG; Diliberto JJ; Birnbaum LS
Toxicol Appl Pharmacol; 1996 May; 138(1):98-109. PubMed ID: 8658519
[TBL] [Abstract][Full Text] [Related]
12. The use of toxic equivalency factor distributions in probabilistic risk assessments for dioxins, furans, and PCBs.
Finley BL; Connor KT; Scott PK
J Toxicol Environ Health A; 2003 Mar; 66(6):533-50. PubMed ID: 12712595
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of relative potencies for in vitro transactivation of the baikal seal aryl hydrocarbon receptor by dioxin-like compounds.
Kim EY; Suda T; Tanabe S; Batoev VB; Petrov EA; Iwata H
Environ Sci Technol; 2011 Feb; 45(4):1652-8. PubMed ID: 21204517
[TBL] [Abstract][Full Text] [Related]
14. A sensitivity analysis using alternative toxic equivalency factors to estimate U.S. dietary exposures to dioxin-like compounds.
Parvez S; Evans AM; Lorber M; Hawkins BS; Swartout JC; Teuschler LK; Rice GE
Regul Toxicol Pharmacol; 2013 Nov; 67(2):278-84. PubMed ID: 23973911
[TBL] [Abstract][Full Text] [Related]
15. Relative effective potencies of dioxin-like compounds in rodent and human lung cell models.
Strapáčová S; Brenerová P; Krčmář P; Andersson P; van Ede KI; van Duursen MBM; van den Berg M; Vondráček J; Machala M
Toxicology; 2018 Jul; 404-405():33-41. PubMed ID: 29738842
[TBL] [Abstract][Full Text] [Related]
16. Modeling and assaying dioxin-like biological effects for both dioxin-like and certain non-dioxin-like compounds.
Wilkes JG; Hass BS; Buzatu DA; Pence LM; Archer JC; Beger RD; Schnackenberg LK; Halbert MK; Jennings L; Kodell RL
Toxicol Sci; 2008 Mar; 102(1):187-95. PubMed ID: 18065775
[TBL] [Abstract][Full Text] [Related]
17. Levels of PCDDs, PCDFs, and dioxin-like PCBs in human milk among Hong Kong mothers.
Wong TW; Wong AH; Nelson EA; Qiu H; Ku SY
Sci Total Environ; 2013 Oct; 463-464():1230-8. PubMed ID: 22939609
[TBL] [Abstract][Full Text] [Related]
18. Dioxin-like toxicity in the Saginaw River Watershed: polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls in sediments and floodplain soils from the Saginaw and Shiawassee Rivers and Saginaw Bay, Michigan, USA.
Kannan K; Yun SH; Ostaszewski A; McCabe JM; Mackenzie-Taylor D; Taylor AB
Arch Environ Contam Toxicol; 2008 Jan; 54(1):9-19. PubMed ID: 17917761
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of toxic equivalency factors for induction of cytochromes P450 CYP1A1 and CYP1A2 enzyme activity by dioxin-like compounds.
Toyoshiba H; Walker NJ; Bailer AJ; Portier CJ
Toxicol Appl Pharmacol; 2004 Jan; 194(2):156-68. PubMed ID: 14736496
[TBL] [Abstract][Full Text] [Related]
20. Comparative ability of various PCBs, PCDFs, and TCDD to induce cytochrome P450 1A1 and 1A2 activity following 4 weeks of treatment.
De Vito MJ; Maier WE; Diliberto JJ; Birnbaum LS
Fundam Appl Toxicol; 1993 Jan; 20(1):125-30. PubMed ID: 8432423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
